University Hospital Aachen-ko ikertzaileekin lankidetzan egindako argitalpenak (10)

2021

  1. A Model-Based Workflow to Benchmark the Clinical Cholestasis Risk of Drugs

    Clinical Pharmacology and Therapeutics, Vol. 110, Núm. 5, pp. 1293-1301

2019

  1. A physiology-based model of human bile acid metabolism for predicting bile acid tissue levels after drug administration in healthy subjects and bric type 2 patients

    Frontiers in Physiology, Vol. 10, Núm. SEP

2000

  1. Hepatic cytochrome P450 down-regulation during aseptic inflammation in the mouse is interleukin 6 dependent

    Hepatology, Vol. 32, Núm. 1, pp. 49-55

1997

  1. Hepatocyte growth factor/scatter factor (HGF/SF) signals via the STAT3/APRF transcription factor in human hepatoma cells and hepatocytes

    FEBS Letters, Vol. 405, Núm. 1, pp. 99-103

1990

  1. Acute‐phase response of human hepatocytes: Regulation of acute‐phase protein synthesis by interleukin‐6

    Hepatology, Vol. 12, Núm. 5, pp. 1179-1186

  2. Fate of interleukin‐6 in the rat: Involvement of skin in its catabolism

    European Journal of Biochemistry, Vol. 189, Núm. 1, pp. 113-118

  3. Interleukin-6 and the acute phase response

    Biochemical Journal, Vol. 265, Núm. 3, pp. 621-636

1989

  1. Fate and biological action of human recombinant interleukin 1β in the rat in vivo

    European Journal of Immunology, Vol. 19, Núm. 8, pp. 1485-1490

  2. Interleukin‐6: The Major Regulator of Acute‐Phase Protein Synthesis in Man and Rat

    Annals of the New York Academy of Sciences, Vol. 557, Núm. 1, pp. 87-101

  3. O- and N-glycosylation lead to different molecular mass forms of human monocyte interleukin-6

    FEBS Letters, Vol. 247, Núm. 2, pp. 323-326